Snowball logo
logo
DMP

Dermapharm Holding SE

DMP • XETRA
€37.85-€0.55  (1.43%)
Estimate
P/E
13.7
EPS
2.77
Beta
0.866
Growth
Revenue, YoY
4.78%
Net income, YoY
11.15%
FCF, YoY
-48.52%
Forecast
P/E (FWD)
12.8
EPS (FWD)
2.967
Dividends
Dividend yield
2.32%
Annual payout
€0.88
Next ex. div date
June 29, 27
Payout
66.13%
Div.growth, 5y
2.38%
Div.rating
About the company
Ticker
DMP
ISIN
DE000A2GS5D8
Country
Germany
Sector (GICS)
Healthcare
Dermapharm Holding SE, together with its subsidiaries, manufactures and sells off-patent branded pharmaceutical products in Germany, Italy, France, Austria, Switzerland, Spain, Portugal, the Netherlands, Croatia, Poland, Ukraine, the United States, and China. The company operates through three segments: Branded Pharmaceuticals; Other Healthcare Products; and Parallel Import Business. It offers branded generics, OTC products, non-prescription healthcare products, and herbal extracts and parallel-imported originator pharmaceuticals. The company also provides vitamins, minerals, food supplements, as well as products for dermatology, allergology, pain and inflammation treatment, cardiovascular support, gynecology, and urology. In addition, it offers cosmetics and medical devices. Further, the company imports originator pharmaceuticals under the axicorp brand. It sells its products under the Dekristol, Keltican, Tromcardin, Ketozolin, bite away, and Herpotherm brands. The company was founded in 1991 and is headquartered in Grünwald, Germany. Dermapharm Holding SE is a subsidiary of Themis Beteiligungs-AG.

Frequently asked questions

What sector does Dermapharm Holding SE (DMP) operate in?

Dermapharm Holding SE belongs to the Healthcare sector and operates in the Drug Manufacturers - Specialty & Generic industry.

What is Dermapharm Holding SE (DMP) current stock price?

As of the latest data, Dermapharm Holding SE stock price is €37.85, with a previous close of €38.40. Dermapharm Holding SE lost -€0.55 in the last trading session, representing a -1.43% loss.

What is Dermapharm Holding SE (DMP) current market capitalization?

Dermapharm Holding SE market cap is approximately 1.88 billion.

What is Dermapharm Holding SE (DMP) Earnings Per Share (EPS)?

The trailing EPS is €2.77, and the forward EPS is €2.97.

What is Dermapharm Holding SE (DMP) Price-to-Earnings (P/E) ratio?

Dermapharm Holding SE current P/E ratio is 13.66, with a forward P/E of 12.76.

What is Dermapharm Holding SE (DMP) EBITDA?

Dermapharm Holding SE EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is 71.05 million.

Does Dermapharm Holding SE (DMP) pay dividends?

Yes. Dermapharm Holding SE pays annual dividends with an annualized yield of 2.32% and an estimated annual payout of €0.88 per share.

When is the next ex-dividend date for Dermapharm Holding SE (DMP)?

The next ex-dividend date is scheduled for June 29, 2027.

When is Dermapharm Holding SE (DMP) next earnings report?

Dermapharm Holding SE is expected to release its next earnings report on September 30, 2026.

What is Dermapharm Holding SE (DMP) beta (volatility) score?

Dermapharm Holding SE has a beta of 0.866, meaning its volatility is roughly in line with the market.